AI powered solution for personalised health

Vann提供了一个数字平台，为癌症患者及其他患者提供社区支持，为他们提供有用的资源和工具，并提供研究和调查。通过研究和调查收集的数据将有助于癌症研究和药物开发。在这个项目的范围内，我们计划开发一个人工智能驱动的工具，它将根据患者的治疗阶段为他们提供个性化的信息。这将补充现有的平台，并将利用用户通过有针对性的研究和调查共享的数据。此工具将包含在保费计划中，作为收入的直接来源。B)进行可行性研究，以分析和评估药物基因组学在我们工作中的应用潜力。特别是，将基因组数据与用户的健康和生活方式数据联系起来，将使该工具能够侧重于个性化医疗，以预防癌症，并增进对短期和长期副作用以及癌症治疗对患者生活质量的影响的了解。这笔拨款将有助于加快患者使用Vann优雅而复杂的平台，并将允许更早的商业化。

Vann provides a digital platform that offers community support to people living with cancer and beyond, provides them with helpful resources and tools, as well as offers studies and surveys to take part in. Real World Data collected though studies and surveys will contribute to cancer research and drug development.Within the scope of this project, we plan toa) develop an AI powered tool, which will offer personalised information to patients based on their stage of treatment. This will supplement the existing platform and will leverage data that the users share through targeted research studies and surveys. This tool will be included in the premium plan, serving as a direct source of revenue.b) conduct a feasibility study in order to analyse and evaluate the potential for the application of pharmacogenomics in our work. In particular, connecting genomic data with health and lifestyle data of users will enable the tool to focus on personalised medicine for the purposes of cancer prevention and to improve understanding of short-term and long-term side effects as well as the impact of cancer treatments on the quality of life of patients.This grant funding will help to accelerate patient access to Vann's elegant and sophisticated platform and it will also allow earlier commercialisation.